- Home
- SBS vs ICLR Comparison
SBS vs ICLR Comparison
Compare SBS & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBS
- ICLR
- Stock Information
- Founded
- SBS 1954
- ICLR 1990
- Country
- SBS Brazil
- ICLR Ireland
- Employees
- SBS N/A
- ICLR N/A
- Industry
- SBS Water Supply
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- SBS Utilities
- ICLR Health Care
- Exchange
- SBS Nasdaq
- ICLR Nasdaq
- Market Cap
- SBS 14.4B
- ICLR 14.3B
- IPO Year
- SBS 2002
- ICLR 1998
- Fundamental
- Price
- SBS $25.59
- ICLR $160.22
- Analyst Decision
- SBS
- ICLR Buy
- Analyst Count
- SBS 0
- ICLR 15
- Target Price
- SBS N/A
- ICLR $205.07
- AVG Volume (30 Days)
- SBS 1.1M
- ICLR 903.5K
- Earning Date
- SBS 11-10-2025
- ICLR 10-22-2025
- Dividend Yield
- SBS 2.13%
- ICLR N/A
- EPS Growth
- SBS N/A
- ICLR N/A
- EPS
- SBS 1.98
- ICLR 7.47
- Revenue
- SBS $6,502,517,346.00
- ICLR $8,102,602,000.00
- Revenue This Year
- SBS N/A
- ICLR N/A
- Revenue Next Year
- SBS N/A
- ICLR $0.89
- P/E Ratio
- SBS $13.23
- ICLR $20.94
- Revenue Growth
- SBS N/A
- ICLR N/A
- 52 Week Low
- SBS $13.87
- ICLR $125.10
- 52 Week High
- SBS $27.12
- ICLR $228.29
- Technical
- Relative Strength Index (RSI)
- SBS 56.04
- ICLR 40.05
- Support Level
- SBS $25.35
- ICLR $155.00
- Resistance Level
- SBS $27.12
- ICLR $167.43
- Average True Range (ATR)
- SBS 0.45
- ICLR 5.92
- MACD
- SBS 0.03
- ICLR -0.53
- Stochastic Oscillator
- SBS 46.73
- ICLR 32.49
About SBS Companhia de saneamento Basico
Companhia De Saneamento Basico Do Estado De Sao Paulo is engaged in the provision of basic and environmental sanitation services in the Sao Paulo State and supplies treated water and sewage services on a wholesale basis. The company operates in a single segment, which is Sanitation services.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.